You are here: Industry Insights > Novavax

News List

Multiple rolling reviews kick-off for Novavax’s COVID-19 vaccine pharmatimes
February 05, 2021
Rolling reviews of Novavax’s COVID-19 vaccine have kicked-off in the UK, US, EU and Canada following the recent announcement that the jab demonstrated 89.3% efficacy in a phase III trial.
Serum Institute of India plans clinical trials of second Covid-19 vaccine pharmaceutical-technology
February 02, 2021
Serum Institute of India (SII) has announced plans to conduct clinical trials of another Covid-19 vaccine in the country, with hopes to launch it in June.
Serum Institute of India seeks permission for local trials of Novavax vaccine expresspharma
February 01, 2021
Serum Institute of India (SII) has applied to the DCGI to conduct a small domestic trial of Novavax’s COVID-19 vaccine, which was found to be 89.3 per cent effective in a UK trial.
J&J’s COVID-19 vaccine best used to curb outbreak, Novavax’s vaccine for overall protection: GlobalData expresspharma
February 01, 2021
As countries increasingly have weapons against COVID-19 in their armamentarium, increased scrutiny will be placed on the fifth, sixth, and later vaccines to enter the market.
Novavax COVID-19 vaccine 89 per cent effective in UK trial, 60 per cent in South Africa expresspharma
January 29, 2021
Novavax is stockpiling vaccine at six operating manufacturing locations and said it expects a total of eight plants in seven countries to produce at the rate of two billion doses per year, including from the Serum Institute of India.
Japan has pre-ordered COVID-19 vaccine doses for more than four times its population, says report europeanpharmaceuticalreview
January 20, 2021
Japan has procurement deals with half of the companies leading the COVID-19 vaccine development race, according to GlobalData.
Baxter, Novavax Ink Sterile Manufacturing Agreement contractpharma
January 12, 2021
CMO Baxter will help increase commercial production and promote access to Novavax' Covid-19 vax in UK and European markets.
Novavax announces initiation of PREVENT-19 pivotal Phase 3 efficacy trial of COVID-19 vaccine in the United States and Mexico worldpharmanews
December 29, 2020
Novavax, Inc. announced initiation of PREVENT-19, its pivotal Phase 3 study in the United States and Mexico to evaluate the efficacy, safety and immunogenicity of NVX-CoV2373, the Company's COVID-19 vaccine candidate.
Serum Institute says in active talks with Indian government around potential COVID-19 vaccines expresspharma
November 30, 2020
Serum Institute of India (SII) is in active discussions with the Indian government on pricing and distribution of potential COVID-19 vaccines, said Adar Poonawalla, Chief Executive SII.
FDA grants Fast Track Designation to Novavax COVID-19 vaccine candidate europeanpharmaceuticalreview
November 13, 2020
The FDA has given Fast Track Designation to NVX-CoV2373, Novavax’s COVID-19 vaccine candidate, created using recombinant nanoparticle technology.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 14 15 Next page